Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation

Citation
N. Vacaresse et al., Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation, BR J PHARM, 132(8), 2001, pp. 1777-1788
Citations number
48
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
132
Issue
8
Year of publication
2001
Pages
1777 - 1788
Database
ISI
SICI code
0007-1188(200104)132:8<1777:PATACA>2.0.ZU;2-G
Abstract
1 Oxidized low density lipoproteins (oxLDL) are thought to play a major rol e in atherosclerosis. OxLDL act in part through alteration of intracellular signalling pathways in cells of the vascular wall. We recently reported th at the EGF receptor (EGFR) signalling pathway is activated by lipid peroxid ation products (among them 4-hydroxynonenal, 4-HNE) contained in oxLDL. 2 The use of phenolic antioxidants, such as trolox, alpha-tocopherol, caffe ic acid and tyrphostins A-25, A-46 or A-1478, showed that the oxLDL-induced EGFR activation is constituted by two separate components, the first (earl y) one being antioxidant-insensitive, the second (late) being antioxidant-s ensitive. 3 4-HNE derivatization of EGFR and EGFR activation induced by exogenous 4-H NE, suggest that the early (0.5-3 h) component of oxLDL-induced EGFR activa tion is mediated (at least in part) by 4-HNE (and possibly by other oxidize d lipids). This early component is antioxidant-insensitive. 4 The second component (4-5 h) of the oxLDL-induced EGFR activation is anti oxidant-sensitive, since it is blocked by antioxidants such as trolox, caff eic acid or PDTC, which act by blocking the cellular oxidative stress (H2O2 generation) evoked by oxLDL. Conversely, exogenous H2O2 induced EGFR autop hosphorylation (thus mimicking the second component) and was also inhibited by antioxidants. This effect is mediated in part through inhibition by oxi dative stress of protein tyrosine phosphatases involved in EGFR dephosphory lation.